Recent advances in cellular imaging enable unprecedented dynamic and spatial resolution in studies of cells, tissues, and animals, creating exciting opportunities for discovery in a broad range of basic and translational research aimed at understanding human diseases. The Washington University Center for Cellular Imaging (WUCCI) provides access to cutting-edge microscopy and sample preparation equipment along with technical expertise to promote and facilitate the highest possible quality cellular imaging and analysis in these studies.
In order to enable investigators to jump-start their research studies using the WUCCIs resources the following seed funding programs are available:
As a part of the DRC Cell and Tissue Imaging Core, we are pleased to be able to offer scholarships to DRC members to support the use of advanced cellular imaging and analysis tools to basic and translational studies of diabetes. The scholarship program will provide a funds of $500 (for smaller projects) or $1000 (for larger projects) for use in covering the costs of cellular imaging studies using the WUCCI, with the goal of scholarship support covering 50% of the expected chargebacks for expected project expenses. The scholarships will be awarded on a first-come-first-served basis, and must be expended within the grant year when awarded.
Eligibility: DRC members with a faculty appointment.
PLEASE NOTE: The following acknowledgement must be used when publishing or presenting work funded by this micro-grant program: “Funding for this project was provided by the Washington University Diabetes Research Center (P30 DK020579).”
As a part of the RDRRC Cellular Imaging Core, we are pleased to be able to offer micro-grants to RDRRC members to support the use of advanced cellular imaging and analysis tools to accelerate the pace, expand the scope, and improve the efficiency of rheumatic diseases research. The micro-grant program will cover approximately 50% of the chargeback costs of a given imaging project up to a maximum of $2,000 for junior faculty and $1,000 for other members. The micro-grants will be awarded on a first-come-first-served basis, and must be expended within the grant year when awarded.
Eligibility: RDRRC members with a faculty appointment.
PLEASE NOTE: The following acknowledgement must be used when publishing or presenting work funded by this micro-grant program: “Funding for this project was provided by the Washington University Rheumatic Diseases Research Resource-based Center (P30 AR073752).”
The Just-In-Time (JIT) Core Usage Funding Program is designed to provide quick access to funding to use any of the ICTS-Affiliated Cores for research advancing medical knowledge that can improve human health. A Confirmation Form from the Director of the ICTS-Affiliated Core will provide the requested service(s) is an essential part of the application and must corroborate the service(s) to be provided and the interaction the investigator has had with the Core in determining the relevant services.
This program is designed to support investigators in obtaining final data 1) for developing a clinical/translational proposal to be submitted for extramural funding or 2) leading to a concrete improvement in patient care at Barnes-Jewish Hospital or St. Louis Children’s Hospital. Details are required in the application.
- Applicant must be a registered member of the ICTS. See ICTS Registration Guidelines for details and online registration. For assistance with registration, contact the ICTS office via email at email@example.com.
- Applicants from WU or its ICTS partner academic institutions must hold a faculty level appointment and employees of BJH, Goldfarb School of Nursing or SLCH (MD, PhD, RN, or allied healthcare professional) may apply with the permission of their department director.
- For research fellows or trainees, the mentor (faculty member) must submit the application as PI.
- Applicants may hold only one JIT Core Usage award at a time, and total awarded services may not exceed $5,000* within a 12 month period (*Maximum for Human Imaging Unit is $10,000).
- Funds may be requested for services from up to 2 Cores maximum, per JIT application.
Investigators submit their application via the online submission system to the core(s) from which they are requesting services PRIOR to the deadline to allow appropriate time for review. We recommend consulting with the core(s) in order to determine the timeline for your application.
The ICTS JIT Core Usage Funding Application site: http://ictsapply.dom.wustl.edu
Core directors complete their portion of the application and submit to ICTS. In order for the application to be considered for a current deadline, the core(s) must approve the applications online before 5 pm CST on the 10th of a month (or the first working day after the 10th). Those received after the 10th will be held until the reviews of the following month.
Applications received before 5pm CST on the 10th of the month (or the first working day thereafter) will be reviewed and responded to by the 10th of the next month (or the first working day thereafter). Those received after the 10th will be held for review the following month.
All proposals will be reviewed by a committee that includes the ICTS Research Funding Program Director and Co-Directors, and invited ICTS faculty as subject area experts. Investigators approved for an award will not receive hard funds. Essentially, a voucher will be issued for the requested services. Upon completion of the services, Core(s) will issue an invoice to the ICTS Administrative Core and, in turn, receive payment. Funds for ICTS specific services will be available to the investigator for up to one year.
The JIT Core Usage Funding Program is funded by the WU Institute of Clinical and Translational Sciences, Mallinckrodt Institute of Radiology, Barnes-Jewish Hospital Foundation, and St. Louis Children’s Hospital.
PLEASE NOTE: Use of any ICTS Core or service requires the following NIH Funding Acknowledgement for all publications and projects.
“Research reported in this publication was supported by the Washington University Institute of Clinical and Translational Sciences grant UL1 TR000448 from the National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official view of the NIH.”